AtriCure (ATRC) Misses Q4 EPS by 13c, provides guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to AtriCure (ATRC) Misses Q4 EPS by 13c, provides guidance

AtriCure Inc. (ATRC) PT Raised to $57 at BTIG

February 13, 2025 5:21 AM EST

BTIG analyst Marie Thibault raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $57.00 (from $53.00) while maintaining a Buy rating.

The analyst comments "AtriCure announced Q4 revenue of $124.3M (+16.6% y/y rep, +16.7% y/y cc), in line with the preliminary announcement last month. This result came in above the implied Q4 guidance range of $118M-$121M, beating consensus and our forecast of $119.8M at the time of the pre-announcement. U.S.... More